CTNM
Contineum Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.00
-0.86 ▼ -6.20%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$13.00
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -2.18 | Insider Own | 25.59% | Shs Outstand | 0.03B | Perf Week | -6.34% |
| Market Cap | 0.50B | Forward P/E | - | EPS next Y | -5.8% | Insider Trans | -0.44% | Shs Float | 0.03B | Perf Month | -14.81% |
| Enterprise Value | 0.25B | PEG | - | EPS next Q | -0.53 | Inst Own | 68.27% | Short Float | 8.84% | Perf Quarter | 3.83% |
| Income | -0.06B | P/S | - | EPS this Y | 5.27% | Inst Trans | 36.67% | Short Ratio | 10.42 | Perf Half Y | 10.08% |
| Sales | 0.00B | P/B | 1.86 | EPS next 5Y | -1.56% | ROA | -24.42% | Short Interest | 2.55M | Perf YTD | 13.74% |
| Book/sh | 6.99 | P/C | 1.92 | EPS past 3/5Y | -30.91% - | ROE | -26.13% | 52W High | -20.39% ($16.33) | Perf Year | 82.07% |
| Cash/sh | 6.78 | P/FCF | - | Sales past 3/5Y | - | ROIC | -22.47% | 52W Low | 288.06% ($3.35) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -33.17% | Gross Margin | - | Volatility(W/M) | 10.8% 7.83% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 1.19 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 27.5 | EPS Q/Q | 12.82% | Profit Margin | - | RSI (14) | 41.24 | Recom | 1.43 |
| Dividend Gr. 3/5Y | - | Current Ratio | 27.5 | Sales Q/Q | - | SMA20 | -11.92% ($14.76) | Beta | 1.24 | Target Price | $22 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 3000000 | SMA50 | -3.84% ($13.52) | Rel Volume | 0.93 | Prev Close | $13.86 |
| Employees | 51 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | -26.03% -100% | SMA200 | 29.43% ($10.04) | Avg Volume(3M) | 0.24M | Price | $13 |
| IPO | 2024/4/5 | Option/Short | Yes/Yes | Trades | 4802 | Volume | 228,111 | Change | -6.2% |
뉴스 로딩 중...